Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 811 | 1,478 | 1,143 | 762 | 235 |
| Cost of Goods | 793 | 1,436 | 1,218 | 723 | 163 |
| Gross Profit | 18 | 42 | -75 | 39 | 72 |
| Operating Expenses | 1,666 | 989 | 800 | 1,235 | 498 |
| Operating Income | -855 | -511 | -657 | -473 | -263 |
| Other Income | -4 | -1 | 140 | -60 | -41 |
| Pre-tax Income | -859 | -512 | -517 | -533 | -304 |
| Net Income Continuous | -859 | -512 | -517 | -533 | -304 |
| Net Income | $-859 | $-512 | $-517 | $-533 | $-304 |
| EPS Basic Total Ops | -0.03 | -0.02 | -0.01 | -0.02 | -0.01 |
| EPS Basic Continuous Ops | -0.03 | -0.02 | -0.02 | -0.02 | -0.01 |
| EPS Diluted Total Ops | -0.03 | -0.02 | -0.01 | -0.02 | -0.01 |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | -0.02 | -0.02 | -0.01 |
| EBITDA(a) | $-841 | $-496 | $-653 | $-468 | $-259 |